175 related articles for article (PubMed ID: 38165377)
21. Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis.
Rosenstein I; Axelsson M; Novakova L; Malmeström C; Blennow K; Zetterberg H; Lycke J
J Neurol; 2023 Oct; 270(10):4800-4811. PubMed ID: 37314506
[TBL] [Abstract][Full Text] [Related]
22. Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.
Tsagkas C; Huck-Horvath A; Cagol A; Haas T; Barakovic M; Amann M; Ruberte E; Melie-Garcia L; Weigel M; Pezold S; Schlaeger R; Kuhle J; Sprenger T; Kappos L; Bieri O; Cattin P; Granziera C; Parmar K
Mult Scler; 2023 May; 29(6):702-718. PubMed ID: 36550626
[TBL] [Abstract][Full Text] [Related]
23. Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.
Bernitsas E; Bao F; Seraji-Bozorgzad N; Chorostecki J; Santiago C; Tselis A; Caon C; Zak I; Millis S; Khan O
Mult Scler Relat Disord; 2015 Jan; 4(1):47-51. PubMed ID: 25787052
[TBL] [Abstract][Full Text] [Related]
24. Risk of secondary progressive multiple sclerosis after early worsening of disability.
Dzau W; Sharmin S; Patti F; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Ozakbas S; Gerlach O; Boz C; Grammond P; Terzi M; Amato MP; La Spitaleri D; Ramo-Tello C; Maimone D; Cartechini E; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Iuliano G; Soysal A; Kalincik T
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):984-991. PubMed ID: 37414538
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis.
Prosperini L; Ruggieri S; Haggiag S; Tortorella C; Pozzilli C; Gasperini C
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34373345
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis.
Lauerer M; McGinnis J; Bussas M; El Husseini M; Pongratz V; Engl C; Wuschek A; Berthele A; Riederer I; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
J Neurol Neurosurg Psychiatry; 2023 Dec; 95(1):37-43. PubMed ID: 37495267
[TBL] [Abstract][Full Text] [Related]
27. Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis.
Calvi A; Tur C; Chard D; Stutters J; Ciccarelli O; Cortese R; Battaglini M; Pietroboni A; De Riz M; Galimberti D; Scarpini E; De Stefano N; Prados F; Barkhof F
Neuroimage Clin; 2022; 35():103048. PubMed ID: 35598462
[TBL] [Abstract][Full Text] [Related]
28. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
[TBL] [Abstract][Full Text] [Related]
29. Spinal cord volume loss: A marker of disease progression in multiple sclerosis.
Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
Neurology; 2018 Jul; 91(4):e349-e358. PubMed ID: 29950437
[TBL] [Abstract][Full Text] [Related]
30. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.
Moccia M; Prados F; Filippi M; Rocca MA; Valsasina P; Brownlee WJ; Zecca C; Gallo A; Rovira A; Gass A; Palace J; Lukas C; Vrenken H; Ourselin S; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Barkhof F;
Ann Neurol; 2019 Nov; 86(5):704-713. PubMed ID: 31385358
[TBL] [Abstract][Full Text] [Related]
32. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
Kappos L; Wolinsky JS; Giovannoni G; Arnold DL; Wang Q; Bernasconi C; Model F; Koendgen H; Manfrini M; Belachew S; Hauser SL
JAMA Neurol; 2020 Sep; 77(9):1132-1140. PubMed ID: 32511687
[TBL] [Abstract][Full Text] [Related]
33. Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
Valsasina P; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Yiannakas M; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Filippi M; Rocca MA;
Mult Scler; 2022 May; 28(6):885-899. PubMed ID: 34605323
[TBL] [Abstract][Full Text] [Related]
34. Multiple Sclerosis Progression and Relapse Activity in Children.
Iaffaldano P; Portaccio E; Lucisano G; Simone M; Manni A; Guerra T; Paolicelli D; Betti M; De Meo E; Pastò L; Razzolini L; Rocca MA; Ferrè L; Brescia Morra V; Patti F; Zaffaroni M; Gasperini C; De Luca G; Ferraro D; Granella F; Pozzilli C; Romano S; Gallo P; Bergamaschi R; Coniglio MG; Lus G; Vianello M; Banfi P; Lugaresi A; Totaro R; Spitaleri D; Cocco E; Di Palma F; Maimone D; Valentino P; Torri Clerici V; Protti A; Maniscalco GT; Salemi G; Pesci I; Aguglia U; Lepore V; Filippi M; Trojano M; Amato MP;
JAMA Neurol; 2024 Jan; 81(1):50-58. PubMed ID: 38010712
[TBL] [Abstract][Full Text] [Related]
35. Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.
Aymerich FX; Auger C; Alonso J; Alberich M; Sastre-Garriga J; Tintoré M; Montalban X; Rovira A
AJNR Am J Neuroradiol; 2018 Feb; 39(2):399-404. PubMed ID: 29284602
[TBL] [Abstract][Full Text] [Related]
36. Progression Independent of Relapse Activity in Multiple Sclerosis: Closer to Solving the Pathologic Puzzle.
Tur C; Rocca MA
Neurology; 2024 Jan; 102(1):e207936. PubMed ID: 38165383
[TBL] [Abstract][Full Text] [Related]
37. Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.
Hagström IT; Schneider R; Bellenberg B; Salmen A; Weiler F; Köster O; Gold R; Lukas C
J Neurol; 2017 Jul; 264(7):1402-1412. PubMed ID: 28600596
[TBL] [Abstract][Full Text] [Related]
38. Cervical cord lesion load is associated with disability independently from atrophy in MS.
Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
[TBL] [Abstract][Full Text] [Related]
39. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis.
Zurawski J; Glanz BI; Healy BC; Tauhid S; Khalid F; Chitnis T; Weiner HL; Bakshi R
J Neurol Sci; 2019 Aug; 403():38-43. PubMed ID: 31207364
[TBL] [Abstract][Full Text] [Related]
40. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
